High-Confidence Multiomics + Deep Discovery at 1 Cent per Cell
Stop by the Hamilton suite to learn about BD Biosciences’ continuous ecosystem of single-cell multiomics solutions to power what matters to you in your research. From flexible sample preservation and optimized protein profiling to scalable cell barcoding to a comprehensive suite of single-cell assays and intuitive bioinformatic tools, we’ve got everything you need. Our solutions are built and tested to deliver consistent and best-in-class performance.
Sponsor Workshop
In-Suite Talks: 8 a.m. - 8:45 a.m. in the Hamilton Suite
Doing More with Less: Modern Benchmarking Approaches for Single-Cell Analysis in Resource-Constrained Environments: A Customer Perspective
Join Luciano Martelotto and other single-cell multiomics thought leaders for a forward-looking discussion on transformative innovations and the future of single-cell multiomics.
Moderator: Luciano Martelotto, PhD, Director of Global Market Development (Single Cell), BD Biosciences
Ioannis Vlachos, PhD, Director of Spatial Technologies, Beth Israel Deaconess Medical Center Jasmine Plummer, PhD, Director of the Center for Spatial Omics, St. Jude Children's Hospital Catharine Aquino, MS, Group Leader Genomics Analytics, Functional Genomics Center Zurich Linda Orzolek, MS, MB(ASCP), VP of Operations & Corporate Strategy, OMAPix Inc. |
Beyond Boundaries: Scalable and Flexible Automation for Single-Cell Multiomics Discover how scalable and flexible automation enhances single-cell multiomics on the BD Rhapsody™ platform. This session explores strategies to streamline workflows, boost throughput and improve reproducibility, enabling researchers to accelerate insights.
Jamie Moskwa, Engineering Manager, Instruments and Automation, scM, BD Biosciences |
Preserve Today, Discover Tomorrow: Sample Fixation and Storage for Multiomic Success Maintaining sample integrity is critical for generating reliable biological insights, especially in single-cell assays. This session will explore how BD OMICS-Guard™ Sample Preservation Buffer and OMICS-Guard™ CRYO Preservation Buffer safeguard sample quality for multiomic profiling while providing the flexibility needed for efficient batching. We will also preview upcoming assay innovations designed for fixed single-cell and FFPE samples, expanding possibilities for comprehensive multiomic analysis.
Aruna Ayer, PhD, VP of Multiomics, Innovation, and Scientific Affairs, BD Biosciences Luciano Martelotto, PhD, Director of Global Market Development (Single Cell), BD Biosciences |
Panelists
Ioannis Vlachos, PhD
Harvard Medical School (HMS)
Ioannis Vlachos is the Associate Professor of Pathology, Harvard Medical School (HMS), and the Director of the Spatial Technologies Unit of the HMS Initiative for RNA Medicine. He also directs the Bioinformatics Unit of the Precision RNA Medicine Core and is the co-Director of the Bioinformatics Program of the Cancer Research Institute (CRI), a Member of the Dana Farber / Harvard Cancer Center, and an Associate Faculty of the Broad Institute of MIT & Harvard.
Jasmine Plummer, PhD
St. Jude Children’s Research Hospital.
Jasmine Plummer is an Associate Member of the Department of Developmental Neurobiology at St. Jude Children’s Research Hospital. Dr. Plummer is also the Director of the Center for Spatial Omics at St. Jude. Her research focuses on using a multi-omics approach to examine genetic risk as a factor of oncogenesis.
Catharine Aquino, MS
Functional Genomics Center Zurich
Catharine Aquino leads and coordinates the Genomics workflows and applications at FGCZ. Together with her team, she supports a large variety of analytical workflows such as NGS, long read sequencing, single cell sequencing and spatial gene expression. Catharine represents the FGCZ in the Core for Life Genomics workgroup and the Genomics Research Group of the ABRF.
Linda Orzolek MS, MB (ASCP)
OMAPix Inc.
Over a distinguished two‑decade career at Johns Hopkins University, Linda Orzolek spearheaded the evolution of the core lab, guiding its transition from microarray technologies to state‑of‑the‑art spatial transcriptomics. Today, she channels that transformative leadership into OMAPix Inc., a rapidly expanding CRO in Frederick committed to shaping the future of personalized and precision medicine.
